FDA Clearance Tracker · K252954
MammoSightAI
Last checked: Nov 19, 2026Latest source record: May 4, 2026 (this decision)Source: openFDAMethods & limitations
Decided
May 4, 2026
Substantially Equivalent
Time to decision
230 days
Received Sep 16, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K252954
- Device name
- MammoSightAI
- Applicant
- Neurocareai, Inc. (Dba Savelife.Ai)
- Applicant location
- Prosper, TX
- Received
- Sep 16, 2025
- Decided
- May 4, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 892.2080
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QFM. The earliest in FDA's data is K183285, decided Mar 8, 2019.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K252954
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Neurocareai, Inc. (Dba Savelife.Ai)
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- RadioViewAI510(k)
K260936 · Decided Jul 31, 2026 · 133 days after receipt
Device type: System, Image Processing, Radiological (LLZ) · Radiology & Imaging
- CXRDetectAI510(k)
K253751 · Decided Jul 8, 2026 · 225 days after receipt
Device type: Radiological Computer-Assisted Prioritization Software For Lesions (QFM) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.